{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T09:02:05Z","timestamp":1771232525498,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006752","name":"Universidade do Porto","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006752","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Women with pathogenic\/likely pathogenic (P\/LP) variants in <jats:italic>BRCA1\/2<\/jats:italic> genes have an increased lifetime risk of breast and ovarian cancer. Cancer risk management options include intensive breast surveillance (IBS) and risk reducing mastectomy (RRM). This study aims to compare the effect of these strategies on quality of life, anxiety, and depression to enhance shared decision-making.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We retrospectively analysed clinical records of 221 women with P\/LP variants in <jats:italic>BRCA1\/2<\/jats:italic> genes, from 2007 to 2024. A total of 169 questionnaires containing <jats:italic>Hospital Anxiety and Depression Scale (HADS<\/jats:italic>) and <jats:italic>BREAST-Q<\/jats:italic> were sent, from May to September 2024. Ninety-nine women, 48 who had undergone RRM and 51 who had opted for IBS, completed the questionnaires. Patient-reported outcome measures (PROMs) were compared based on their choice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Significant differences were found in age at genetic testing and personal history of breast cancer between the groups. In <jats:italic>BREAST-Q<\/jats:italic>, the IBS group reported higher scores, with statistically significant differences for <jats:italic>Satisfaction with Breasts<\/jats:italic> and <jats:italic>Physical Well-Being: Chest.<\/jats:italic> These differences were only observed in the group of women without personal breast cancer history who underwent RRM.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>No significant differences were found in psychologic distress levels between the IBS and RRM group. Although RRM is an effective method for reducing breast cancer risk in women with P\/LP variants in <jats:italic>BRCA1\/2<\/jats:italic> genes, carriers should be informed of its impact on quality of life. Notably, once a woman is diagnosed with breast cancer, these differences lose effect.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00432-025-06231-9","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T09:02:35Z","timestamp":1748595755000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Quality of life after risk reducing mastectomy in a Portuguese cohort of BRCA pathogenic\/likely pathogenic variant carriers"],"prefix":"10.1007","volume":"151","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8495-4516","authenticated-orcid":false,"given":"Maria","family":"Raposo","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0579-9988","authenticated-orcid":false,"given":"B\u00e1rbara","family":"Peleteiro","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6249-7962","authenticated-orcid":false,"given":"Andr\u00e9","family":"Magalh\u00e3es","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3710-2823","authenticated-orcid":false,"given":"Sandra","family":"Torres","sequence":"additional","affiliation":[]},{"given":"In\u00eas","family":"Insua-Pereira","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Guimar\u00e3es","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5877-2917","authenticated-orcid":false,"given":"Luzia","family":"Garrido","sequence":"additional","affiliation":[]},{"given":"Susy","family":"Costa","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1861-8178","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Fougo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"6231_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004975","volume":"95","author":"Z Baretta","year":"2016","unstructured":"Baretta Z, Mocellin S, Goldin E, Olopade OI, Huo D (2016) Effect of BRCA germline mutations on breast cancer prognosis. Medicine (Baltimore) 95:e4975. https:\/\/doi.org\/10.1097\/MD.0000000000004975","journal-title":"Medicine (Baltimore)"},{"key":"6231_CR2","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1200\/JCO.2007.13.9568","volume":"26","author":"Y Brandberg","year":"2008","unstructured":"Brandberg Y, Sandelin K, Erikson S, Jurell G, Liljegren A, Lindblom A, Lind\u00e9n A, von Wachenfeldt A, Wickman M, Arver B (2008) Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. J Clin Oncol 26:3943\u20133949. https:\/\/doi.org\/10.1200\/JCO.2007.13.9568","journal-title":"J Clin Oncol"},{"issue":"1","key":"6231_CR3","doi-asserted-by":"publisher","first-page":"173e","DOI":"10.1097\/PRS.0000000000000267","volume":"134","author":"SJ Cano","year":"2014","unstructured":"Cano SJ, Klassen AF, Scott A, Alderman A, Pusic AL (2014) Interpreting clinical differences in BREAST-Q scores: minimal important difference. Plast Reconstr Surg 134(1):173e\u2013175e. https:\/\/doi.org\/10.1097\/PRS.0000000000000267","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"6231_CR4","doi-asserted-by":"publisher","first-page":"CD002748","DOI":"10.1002\/14651858.CD002748.pub4","volume":"2018","author":"NE Carbine","year":"2018","unstructured":"Carbine NE, Lostumbo L, Wallace J, Ko H (2018) Risk-reducing mastectomy for the prevention of primary breast cancer. Cochrane Database Syst Rev 2018(4):CD002748. https:\/\/doi.org\/10.1002\/14651858.CD002748.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"6231_CR5","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.ejca.2011.10.020","volume":"48","author":"M den Heijer","year":"2012","unstructured":"den Heijer M, Seynaeve C, Timman R, Duivenvoorden HJ, Vanheusden K, Tilanus-Linthorst M, Menke-Pluijmers MBE, Tibben A (2012) Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: a prospective long-term follow-up study. Eur J Cancer (Oxford, England) 48(9):1263\u20131268. https:\/\/doi.org\/10.1016\/j.ejca.2011.10.020","journal-title":"Eur J Cancer (Oxford, England)"},{"key":"6231_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10549-011-1449-7","volume":"129","author":"SU Dhar","year":"2011","unstructured":"Dhar SU, Cooper HP, Wang T, Parks B, Staggs SA, Hilsenbeck S, Plon SE (2011) Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers. Breast Cancer Res Treat 129:221\u2013227. https:\/\/doi.org\/10.1007\/s10549-011-1449-7","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"6231_CR7","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.annonc.2022.04.007","volume":"33","author":"M Di Maio","year":"2022","unstructured":"Di Maio M, Basch E, Denis F, Fallowfield LJ, Ganz PA, Howell D, Kowalski C, Perrone F, Stover AM, Sundaresan P, Warrington L, Zhang L, Apostolidis K, Freeman-Daily J, Ripamonti CI, Santini D (2022) The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline. Ann Oncol 33(9):878\u2013892. https:\/\/doi.org\/10.1016\/j.annonc.2022.04.007","journal-title":"Ann Oncol"},{"key":"6231_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13053-022-00244-y","volume":"20","author":"J Dick","year":"2022","unstructured":"Dick J, T\u00fcchler A, Br\u00e9dart A, Vitinius F, Wassermann K, Rhiem K, Schmutzler RK (2022) Psychological factors and the uptake of preventative measures in BRCA1\/2 pathogenic variant carriers: results of a prospective cohort study. Hered Cancer Clin Pract 20:38. https:\/\/doi.org\/10.1186\/s13053-022-00244-y","journal-title":"Hered Cancer Clin Pract"},{"key":"6231_CR9","first-page":"1","volume":"90","author":"G Franceschini","year":"2019","unstructured":"Franceschini G, Di Leone A, Terribile D, Sanchez MA, Masetti R (2019) Bilateral prophylactic mastectomy in BRCA mutation carriers: What surgeons need to know. Ann Ital Chir 90:1\u20132","journal-title":"Ann Ital Chir"},{"issue":"18","key":"6231_CR10","doi-asserted-by":"publisher","first-page":"9707","DOI":"10.3390\/ijerph18189707","volume":"18","author":"S Garc\u00eda-Solbas","year":"2021","unstructured":"Garc\u00eda-Solbas S, Lorenzo-Li\u00f1\u00e1n MA, Castro-Luna G (2021) Long-term quality of life (BREAST-Q) in patients with mastectomy and breast reconstruction. Int J Environ Res Public Health 18(18):9707. https:\/\/doi.org\/10.3390\/ijerph18189707","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"6231_CR11","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s10549-019-05345-2","volume":"177","author":"BAM Heemskerk-Gerritsen","year":"2019","unstructured":"Heemskerk-Gerritsen BAM, Jager A, Koppert LB, Obdeijn AI-M, Coll\u00e9e M, Meijers-Heijboer HEJ, Jenner DJ, Oldenburg HSA, van Engelen K, de Vries J, van Asperen CJ, Devilee P, Blok MJ, Kets CM, Ausems MGE, Seynaeve C, Rookus MA, Hooning MJ (2019) Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 177(3):723\u2013733. https:\/\/doi.org\/10.1007\/s10549-019-05345-2","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"6231_CR12","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3390\/genes13081357","volume":"13","author":"N Herold","year":"2022","unstructured":"Herold N, Hellmich M, Lichtenheldt F, Ataseven B, Hillebrand V, Wappenschmidt B, Schmutzler RK, Rhiem K (2022) Satisfaction and quality of life of healthy and unilateral diseased BRCA1\/2 pathogenic variant carriers after risk-reducing mastectomy and reconstruction using the BREAST-Q questionnaire. Genes 13(8):1357. https:\/\/doi.org\/10.3390\/genes13081357","journal-title":"Genes"},{"issue":"2","key":"6231_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jpsychores.2011.01.005","volume":"71","author":"A Hinz","year":"2011","unstructured":"Hinz A, Br\u00e4hler E (2011) Normative values for the hospital anxiety and depression scale (HADS) in the general German population. J Psychosom Res 71(2):74\u201378. https:\/\/doi.org\/10.1016\/j.jpsychores.2011.01.005","journal-title":"J Psychosom Res"},{"issue":"23","key":"6231_CR14","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, Jervis S, van Leeuwen FE, Milne RL, Andrieu N, Goldgar DE, Terry MB, Rookus MA, Easton DF, Antoniou AC, BRCA1 and BRCA2 Cohort Consortium (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317(23):2402\u20132416. https:\/\/doi.org\/10.1001\/jama.2017.7112","journal-title":"JAMA"},{"issue":"4","key":"6231_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1001\/jamaoncol.2023.6944","volume":"10","author":"J Lubinski","year":"2024","unstructured":"Lubinski J, Kotsopoulos J, Moller P, Pal T, Eisen A, Peck L, Karlan BY, Aeilts A, Eng C, Bordeleau L, Foulkes WD, Tung N, Couch FJ, Fruscio R, Ramon y Cajal T, Singer CF, Neuhausen SL, Zakalik D, Cybulski C, Hereditary Breast Cancer Clinical Study Group (2024) MRI surveillance and breast cancer mortality in women with BRCA1 and BRCA2 sequence variations. JAMA Oncol 10(4):493\u2013499. https:\/\/doi.org\/10.1001\/jamaoncol.2023.6944","journal-title":"JAMA Oncol"},{"issue":"1","key":"6231_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cireng.2021.06.014","volume":"100","author":"S Luque Su\u00e1rez","year":"2022","unstructured":"Luque Su\u00e1rez S, Olivares Crespo ME, Brenes S\u00e1nchez JM, Herrera De La Muela M (2022) Psychological implications of risk-reducing mastectomies in BRCA1\/2 mutation carriers. Cir Esp (Engl Ed) 100(1):7\u201317. https:\/\/doi.org\/10.1016\/j.cireng.2021.06.014","journal-title":"Cir Esp (Engl Ed)"},{"issue":"12","key":"6231_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2021.104350","volume":"64","author":"DH Marmolejo","year":"2021","unstructured":"Marmolejo DH, Wong MYZ, Bajalica-Lagercrantz S, Tischkowitz M, Balma\u00f1a J, Pat\u00f3cs AB, Chappuis P, Colas C, Genuardi M, Haanp\u00e4\u00e4 M, Vetti HH, Hoogerbrugge N, Irmejs A, Kahre T, Klink B, Krajc M, Milagre TH, de Putter R, Steinke-Lange V, Wimmer K (2021) Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe. Eur J Med Genet 64(12):104350. https:\/\/doi.org\/10.1016\/j.ejmg.2021.104350","journal-title":"Eur J Med Genet"},{"issue":"9","key":"6231_CR18","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1245\/s10434-017-5915-2","volume":"24","author":"CM McCarthy","year":"2017","unstructured":"McCarthy CM, Hamill JB, Kim HM, Qi J, Wilkins E, Pusic AL (2017) Impact of bilateral prophylactic mastectomy and immediate reconstruction on health-related quality of life in women at high risk for breast carcinoma: results of the mastectomy reconstruction outcomes consortium study. Ann Surg Oncol 24(9):2502\u20132508. https:\/\/doi.org\/10.1245\/s10434-017-5915-2","journal-title":"Ann Surg Oncol"},{"key":"6231_CR19","unstructured":"Meneses RF (2020) Psychosocial profile of BRCA genetic mutation carriers. Psic Sa\u00fade Doen\u00e7a. https:\/\/www.academia.edu\/117959877\/Psychosocial_Profile_of_Brca_Genetic_Mutation_Carriers"},{"issue":"1","key":"6231_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41416-019-0446-1","volume":"121","author":"K Metcalfe","year":"2019","unstructured":"Metcalfe K, Eisen A, Senter L, Armel S, Bordeleau L, Meschino WS, Pal T, Lynch HT, Tung NM, Kwong A, Ainsworth P, Karlan B, Moller P, Eng C, Weitzel JN, Sun P, Lubinski J, Narod SA, Hereditary Breast Cancer Clinical Study Group (2019) International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation. Br J Cancer 121(1):15. https:\/\/doi.org\/10.1038\/s41416-019-0446-1","journal-title":"Br J Cancer"},{"issue":"5","key":"6231_CR21","doi-asserted-by":"publisher","first-page":"1046e","DOI":"10.1097\/PRS.0000000000003241","volume":"139","author":"LR Mundy","year":"2017","unstructured":"Mundy LR, Homa K, Klassen AF, Pusic AL, Kerrigan CL (2017) Breast cancer and reconstruction: normative data for interpreting the BREAST-Q. Plast Reconstr Surg 139(5):1046e\u20131055e. https:\/\/doi.org\/10.1097\/PRS.0000000000003241","journal-title":"Plast Reconstr Surg"},{"issue":"12","key":"6231_CR22","doi-asserted-by":"publisher","first-page":"7116","DOI":"10.1245\/s10434-023-14086-y","volume":"30","author":"SP Myers","year":"2023","unstructured":"Myers SP, Tadros AB, Sevilimedu V, Nelson JA, Le T, Garcia P, Morrow M, Lee MK (2023) Satisfaction and well-being after contralateral prophylactic mastectomy among BRCA mutation carriers and non-carriers: a longitudinal analysis of BREAST-Q domains. Ann Surg Oncol 30(12):7116\u20137123. https:\/\/doi.org\/10.1245\/s10434-023-14086-y","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"6231_CR23","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nrc1431","volume":"4","author":"SA Narod","year":"2004","unstructured":"Narod SA, Foulkes WD (2004) BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4(9):665\u2013676. https:\/\/doi.org\/10.1038\/nrc1431","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"6231_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/13548500500524088","volume":"12","author":"J Pais-Ribeiro","year":"2007","unstructured":"Pais-Ribeiro J, Silva I, Ferreira T, Martins A, Meneses R, Baltar M (2007) Validation study of a Portuguese version of the Hospital Anxiety and Depression Scale. Psychol Health Med 12(2):225\u2013235. https:\/\/doi.org\/10.1080\/13548500500524088","journal-title":"Psychol Health Med"},{"issue":"7","key":"6231_CR25","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1007\/s00432-022-04228-2","volume":"149","author":"CA Pinto","year":"2023","unstructured":"Pinto CA, Peleteiro B, Pinto CS, Os\u00f3rio F, Costa S, Magalh\u00e3es A, Mora H, Amaral J, Gon\u00e7alves D, Fougo JL (2023) Breast cancer patient-reported outcomes on level 1 and level 2 oncoplastic procedures using BREAST-Q\u00ae. J Cancer Res Clin Oncol 149(7):3229\u20133241. https:\/\/doi.org\/10.1007\/s00432-022-04228-2","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"6231_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/PRS.0b013e3181aee807","volume":"124","author":"AL Pusic","year":"2009","unstructured":"Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ (2009) Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg 124(2):345\u2013353. https:\/\/doi.org\/10.1097\/PRS.0b013e3181aee807","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"6231_CR27","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s11136-015-1181-6","volume":"25","author":"SN Razdan","year":"2016","unstructured":"Razdan SN, Patel V, Jewell S, McCarthy CM (2016) Quality of life among patients after bilateral prophylactic mastectomy: a systematic review of patient-reported outcomes. Qual Life Res 25(6):1409\u20131421. https:\/\/doi.org\/10.1007\/s11136-015-1181-6","journal-title":"Qual Life Res"},{"issue":"3","key":"6231_CR28","doi-asserted-by":"publisher","first-page":"249","DOI":"10.21037\/gs.2019.04.08","volume":"8","author":"KE Rojas","year":"2019","unstructured":"Rojas KE, Butler E, Gutierrez J, Kwait R, Laprise J, Wilbur JS, Spinette S, Raker CA, Robison K, Legare R, Gass J, Stuckey A (2019) Choosing high-risk screening vs. surgery and the effect of treatment modality on anxiety and breast-specific sensuality in BRCA mutation carriers. Gland Surg 8(3):249\u2013257. https:\/\/doi.org\/10.21037\/gs.2019.04.08","journal-title":"Gland Surg"},{"issue":"1","key":"6231_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.annonc.2022.10.004","volume":"34","author":"C Sessa","year":"2023","unstructured":"Sessa C, Balma\u00f1a J, Bober SL, Cardoso MJ, Colombo N, Curigliano G, Domchek SM, Evans DG, Fischerova D, Harbeck N, Kuhl C, Lemley B, Levy-Lahad E, Lambertini M, Ledermann JA, Loibl S, Phillips KA, Paluch-Shimon S (2023) Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline. Ann Oncol 34(1):33\u201347. https:\/\/doi.org\/10.1016\/j.annonc.2022.10.004","journal-title":"Ann Oncol"},{"issue":"4","key":"6231_CR30","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3892\/ol.2015.2944","volume":"9","author":"HR Smith","year":"2015","unstructured":"Smith HR (2015) Depression in cancer patients: pathogenesis, implications and treatment (Review). Oncol Lett 9(4):1509\u20131514. https:\/\/doi.org\/10.3892\/ol.2015.2944","journal-title":"Oncol Lett"},{"issue":"10","key":"6231_CR31","doi-asserted-by":"publisher","first-page":"7529","DOI":"10.1007\/s00432-023-04663-9","volume":"149","author":"S Torres","year":"2023","unstructured":"Torres S, Peleteiro B, Magalh\u00e3es A, Garrido L, Costa S, Fougo JL (2023) Differences among a Portuguese cohort of BRCA pathogenic\/likely pathogenic variants carriers choosing risk-reducing mastectomy or intensive breast surveillance. J Cancer Res Clin Oncol 149(10):7529\u20137538. https:\/\/doi.org\/10.1007\/s00432-023-04663-9","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"6231_CR32","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s12282-019-01033-7","volume":"27","author":"LSE Van Egdom","year":"2020","unstructured":"Van Egdom LSE, de Kock MA, Apon I, Mureau MA, Verhoef C, Hazelzet JA, Koppert LB (2020) Patient-Reported Outcome Measures may optimize shared decision-making for cancer risk management in BRCA mutation carriers. Breast Cancer 27(3):426\u2013434. https:\/\/doi.org\/10.1007\/s12282-019-01033-7","journal-title":"Breast Cancer"},{"issue":"12","key":"6231_CR33","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1007\/s00520-011-1251-4","volume":"19","author":"A Vodermaier","year":"2011","unstructured":"Vodermaier A, Millman RD (2011) Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: a systematic review and meta-analysis. Support Care Cancer 19(12):1899\u20131908. https:\/\/doi.org\/10.1007\/s00520-011-1251-4","journal-title":"Support Care Cancer"},{"issue":"6","key":"6231_CR34","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361\u2013370. https:\/\/doi.org\/10.1111\/j.1600-0447.1983.tb09716.x","journal-title":"Acta Psychiatr Scand"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06231-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-025-06231-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06231-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T10:32:28Z","timestamp":1749551548000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-025-06231-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["6231"],"URL":"https:\/\/doi.org\/10.1007\/s00432-025-06231-9","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the Ethics Committee of Unidade Local de Sa\u00fade de S\u00e3o Jo\u00e3o (CE 395-23). Informed consent was obtained from all individual participants included in the study. This research ensured the privacy of patient data, since any sort of personal information allowing identification was not used or shown in the database.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"177"}}